Field Trip Health Ltd (FTRP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FTRP | ZTS | TAK | UTHR | NBIX |
| Company | Field Trip Health Ltd | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 4.2000 | 192.94 | 14.85 | 349.11 | 120.28 |
| High | 4.2505 | 194.55 | 14.87 | 354.70 | 120.28 |
| Low | 4.0705 | 191.07 | 14.76 | 349.11 | 117.00 |
| Last | 4.2105 | 192.64 | 14.80 | 353.00 | 118.35 |
| Change | +0.0445 | -0.60 | -0.13 | +1.67 | -2.11 |
| % Change | +1.07% | -0.31% | -0.87% | +0.48% | -1.75% |
| Volume | 32,880 | 3,520,700 | 1,241,100 | 900,800 | 1,282,500 |
| 20-Day Average Volume | 156,550 | 1,864,715 | 1,545,410 | 402,725 | 1,200,985 |
| Previous Close | 4.1660 | 193.24 | 14.93 | 351.33 | 120.46 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8423 | 188.39 | 14.88 | 349.17 | 126.69 |
| 20-Day Raw Stochastic | 31.74% | 61.84% | 33.33% | 54.20% | 3.57% |
| 20-Day Relative Strength | 48.87% | 60.16% | 57.38% | 57.99% | 33.12% |
| Weighted Alpha | -82.40 | +12.39 | -0.77 | +67.36 | -5.91 |
| Today's Opinion | 72% Sell | 88% Buy | 72% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 72% Sell | 88% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 72% Sell | 56% Buy | 56% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.93% since 08/09/22 | +0.81% since 09/13/24 | +0.68% since 09/13/24 | +4.09% since 09/13/24 | -3.19% since 09/13/24 |
| Low | 0.8101 on 08/15/22 | 191.07 on 09/20/24 | 14.69 on 09/16/24 | 338.40 on 09/16/24 | 117.00 on 09/20/24 |
| High | 0.8650 on 08/12/22 | 200.33 on 09/19/24 | 14.94 on 09/17/24 | 354.70 on 09/20/24 | 123.57 on 09/16/24 |
| 1-Month | |||||
| %Chg | +0.26% since 07/15/22 | +4.92% since 08/20/24 | +0.27% since 08/20/24 | +1.76% since 08/20/24 | -20.88% since 08/20/24 |
| Low | 0.7803 on 08/02/22 | 180.18 on 08/23/24 | 14.66 on 09/13/24 | 337.52 on 09/13/24 | 117.00 on 09/20/24 |
| High | 0.9750 on 07/20/22 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 154.87 on 08/23/24 |
| 3-Month | |||||
| %Chg | -9.78% since 05/16/22 | +14.54% since 06/20/24 | +17.37% since 06/20/24 | +14.25% since 06/20/24 | -11.73% since 06/20/24 |
| Low | 0.7400 on 06/23/22 | 166.45 on 06/26/24 | 12.60 on 06/21/24 | 308.08 on 06/21/24 | 117.00 on 09/20/24 |
| High | 0.9950 on 05/18/22 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 157.98 on 08/01/24 |
| 6-Month | |||||
| %Chg | -47.04% since 02/16/22 | +12.66% since 03/20/24 | +1.72% since 03/20/24 | +49.12% since 03/20/24 | -15.85% since 03/20/24 |
| Low | 0.7100 on 05/10/22 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 221.53 on 04/01/24 | 117.00 on 09/20/24 |
| High | 1.7400 on 03/21/22 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 49,023 | 87,900,672 | 46,839,584 | 15,657,665 | 11,910,389 |
| Shares Outstanding, K | 58,215 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 3,880,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -43,630,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 1,370,000 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 590,200,000 |
| Last Quarter Net Income | -11,210,000 | 624,000,000 | 609,590,000 | 278,100,000 | 65,000,000 |
| 60-Month Beta | N/A | 0.88 | 0.54 | 0.57 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 06/29/22 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.63 on 08/01/24 |
| Latest Earnings Date | 08/15/22 | 11/04/24 | 10/24/24 | 11/06/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 34.88 | 9.51 | 16.15 | 36.39 |